|
시장보고서
상품코드
1812425
세포 동결 배지 시장 : 제품 유형별, 세포 유형별, 동결 보호제 유형별, 용도별, 처방별, 최종 사용자별, 지역별Cell Freezing Media Market, By Product Type, By Cell Type, By Cryoprotectant Type, By Application, By Formulation, By End User, By Geography |
||||||
세포 동결 배지 시장은 2025년에는 19억 2,000만 달러, 2032년에는 36억 8,000만 달러에 이르고, 2025년부터 2032년에 걸쳐 CAGR 9.73%로 성장할 것으로 예상됩니다.
| 보고 범위 | 보고서 세부정보 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 2025년 시장 규모 | 19억 2,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2020-2024년 |
| 예측기간 2025-2032년 CAGR : | 9.73% | 2032년 가치 예측 | 36억 8,000만 달러 |
세계의 세포 동결 배지 시장은 생명 공학 및 제약 산업에 중요한 구성 요소이며 극저온 보존 공정에서 세포의 생존 능력을 유지하는 데 필수적인 보존 솔루션으로 사용됩니다. 세포 동결 배지는 동결보존 배지로도 알려져 있으며, 동결 및 융해 과정에서 얼음 결정 형성이나 삼투압 스트레스로부터 세포 구조를 보호하기 위해 설계된 특수 제제입니다.
이러한 배지는 일반적으로 디메틸 설폭사이드(DMSO), 글리세롤, 초저온에서 세포 생존을 촉진하는 다양한 단백질과 같은 동결 보호제를 포함합니다. 이 시장에는 혈청 함유 제제와 무혈청 제제를 포함한 다양한 제품 유형이 있으며, 각각은 특정 세포 유형 및 연구 용도에 맞게 조정됩니다. 세포 및 유전자 치료 연구, 재생 의료, 바이오뱅킹 활동의 확대에 수반하여, 고품질의 세포 동결 배지에 대한 수요는 대폭적인 성장을 나타내고 있습니다. 이 시장은 제약회사, 생명공학기업, 연구기관, 세포뱅크 등 다양한 최종 사용자에게 서비스를 제공하고 있으며, 해동시 최적의 회수율과 세포기능성을 확보하면서 귀중한 생물학적 샘플과 치료용 세포를 장기간 유지하기 위한 신뢰성 높은 보존 솔루션이 필요합니다.
시장 역학
세계의 세포 동결 배지 시장은 강력한 성장 궤도를 뒷받침하는 몇 가지 주요 요인에 의해 지원됩니다. 그 1차 촉진요인은 세포 및 유전자 치료 연구의 급격한 확대이며, 보존중의 세포 생존율을 유지하는 것이 치료의 성공에 가장 중요합니다. 만성 및 유전성 질환의 유병률 증가는 재생 의학에서 연구 활동을 강화하고 효과적인 동결보존 솔루션에 대한 큰 수요를 창출하고 있습니다. 또한, 줄기세포 연구 이니셔티브의 확대와 함께 세계적으로 바이오뱅크의 수가 증가하고 있는 것도 시장 성장에 크게 기여하고 있습니다. 개인화된 의료 접근의 시작과 환자 고유의 세포의 장기 보존의 필요성은 수요를 더욱 증폭시키고 있습니다.
그러나 시장에는 고급 세포 동결 배지 제제와 관련된 높은 비용이 소규모 연구 기관이나 신흥 생명 공학 기업의 부담이 되는 등 일정한 억제요인도 있습니다. 동물 유래 성분의 동결 배지에의 사용을 둘러싼 규제의 복잡성이 한층 더 과제가 되어, 광범위한 검증 과정이 필요합니다. 또한 품질 관리 요구 사항과 다양한 용도로 표준화된 프로토콜의 필요성도 시장에 대한 액세스를 제한하는 요인이 되었습니다.
이러한 제약이 있음에도 불구하고, 무혈청 배지 및 화학적으로 정의된 배지 제형의 기술적 진보로부터 안전성 및 규제 우려를 다루는 큰 기회가 탄생하고 있습니다. 조직 엔지니어링, 장기 이식 연구 및 새로운 치료법의 개발에서 애플리케이션의 확장은 유리한 성장의 길을 제시합니다. 또한 신흥국의 의료 인프라 투자 증가와 자동 동결보존 시스템 채택 확대로 혁신적인 세포 동결 배지 솔루션에 새로운 시장 기회가 생겨나고 있습니다.
본 조사의 주요 특징
- 본 보고서에서는 세계의 세포 동결 배지 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모(10억 달러)와 연간 평균 성장률(CAGR%)을 제공합니다.
- 다양한 부문에서 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 매개변수를 기반으로 세계 세포 동결 배지 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 통찰을 통해 마케팅 담당자와 기업 경영진이 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- 세계의 세포 동결 배지 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자는 세계의 세포 동결 배지 시장을 분석하는데 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사의 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- PORTER 분석
- 합병과 인수 시나리오
- 업계 동향
제4장 세계의 세포 동결 배지 시장, 제품 유형별, 2020년-2032년
- 혈청 함유 동결 배지
- 무혈청 동결 배지
- 무단백질 동결 배지
- 화학적으로 정의된 동결 배지
제5장 세계의 세포 동결 배지 시장, 세포 유형별, 2020년-2032년
- 포유류 세포 동결 배지
- 줄기 세포 동결배지
- 초대 세포 동결 배지
- 곤충 세포 동결 배지
- 미생물 세포 동결 배지
제6장 세계의 세포 동결 배지 시장, 동결 보호제 유형별, 2020년-2032년
- DMSO 함유 배지
- DMSO 프리 배지
- 글리세롤 기반 배지
제7장 세계의 세포 동결 배지 시장, 용도별, 2020년-2032년
- 줄기세포 보존
- 조직 보존
- 정자 동결
- 난모세포 및 배아 동결
- 재생 의료
제8장 세계의 세포 동결 배지 시장, 처방별, 2020년-2032년
- RTU 처방
- 맞춤/연구 등급 처방
제9장 세계의 세포 동결 배지 시장, 최종 사용자별, 2020년-2032년
- 제약 및 바이오테크놀러지 기업
- 병원 및 진단실험실
- 세포 은행 및 생물 저장소
- 계약연구기관(CRO)
- 기타(학술 및 연구 기관 등)
제10장 세계의 세포 동결 배지 시장, 지역별, 2020년-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제11장 경쟁 구도
- Thermo Fisher Scientific Inc.
- Cytiva(Danaher Corporation)
- Merck KGaA(Sigma-Aldrich)
- Lonza Group AG
- STEMCELL Technologies Inc.
- BioLife Solutions Inc.
- Corning Incorporated
- HiMedia Laboratories Pvt. Ltd.
- FUJIFILM Irvine Scientific Inc.
- MP Biomedicals LLC
- AMSBIO(AMS Biotechnology)
- Nacalai Tesque Inc.
- Cell Applications Inc.
- Miltenyi Biotec BV and Co. KG
- Sartorius AG
제12장 분석가 추천
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제13장 참고문헌과 조사방법
- 참고문헌
- 조사 방법
- 출판사에 대해
Cell Freezing Media Market is estimated to be valued at USD 1.92 Bn in 2025 and is expected to reach USD 3.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.73% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 1.92 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 9.73% | 2032 Value Projection: | USD 3.68 Bn |
The global cell freezing media market represents a critical component of the biotechnology and pharmaceutical industries, serving as an essential preservation solution for maintaining cell viability during cryogenic storage processes. Cell freezing media, also known as cryopreservation media, are specialized formulations designed to protect cellular structures from ice crystal formation and osmotic stress during the freezing and thawing processes.
These media typically contain cryoprotectants such as Dimethyl Sulfoxide (DMSO), glycerol, and various proteins that facilitate cellular survival at ultra-low temperatures. The market encompasses various product types including serum-containing and serum-free formulations, each tailored to specific cell types and research applications. With the expanding scope of cell and gene therapy research, regenerative medicine, and biobanking activities, the demand for high-quality cell freezing media has witnessed substantial growth. The market serves diverse end-users including pharmaceutical companies, biotechnology firms, research institutions, and cell banks, all requiring reliable preservation solutions to maintain valuable biological samples and therapeutic cells for extended periods while ensuring optimal recovery rates and cellular functionality upon thawing.
Market Dynamics
The global cell freezing media market is propelled by several key drivers that collectively fuel its robust growth trajectory. The primary driver stems from the exponential expansion of cell and gene therapy research, where maintaining cell viability during storage is paramount for successful therapeutic outcomes. The increasing prevalence of chronic diseases and genetic disorders has intensified research activities in regenerative medicine, creating substantial demand for effective cryopreservation solutions. Additionally, the growing number of biobanks worldwide, coupled with expanding stem cell research initiatives, significantly contributes to market growth. The rise in personalized medicine approaches and the need for long-term storage of patient-specific cells further amplifies demand.
However, the market faces certain restraints including the high costs associated with premium cell freezing media formulations, which can burden smaller research institutions and emerging biotechnology companies. Regulatory complexities surrounding the use of animal-derived components in freezing media pose additional challenges, necessitating extensive validation processes. Quality control requirements and the need for standardized protocols across different applications can also limit market accessibility.
Despite these constraints, significant opportunities emerge from technological advancements in serum-free and chemically-defined media formulations, addressing safety and regulatory concerns. The expanding applications in tissue engineering, organ transplantation research, and the development of novel therapeutic modalities present lucrative growth avenues. Furthermore, increasing investments in healthcare infrastructure in emerging economies and the growing adoption of automated cryopreservation systems create new market opportunities for innovative cell freezing media solutions.
Key Features of the Study
- This report provides in-depth analysis of the global cell freezing media market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cell freezing media market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Merck KGaA (Sigma-Aldrich), Lonza Group AG, STEMCELL Technologies Inc., BioLife Solutions Inc., Corning Incorporated, HiMedia Laboratories Pvt. Ltd., FUJIFILM Irvine Scientific Inc., MP Biomedicals LLC, AMSBIO (AMS Biotechnology), Nacalai Tesque Inc., Cell Applications Inc., Miltenyi Biotec B.V. and Co. KG, Sartorius AG
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cell freezing media market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell freezing media market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Serum-containing Freezing Media
- Serum-free Freezing Media
- Protein-free Freezing Media
- Chemically-defined Freezing Media
- Cell Type Insights (Revenue, USD Bn, 2020 - 2032)
- Mammalian Cell Freezing Media
- Stem Cell Freezing Media
- Primary Cell Freezing Media
- Insect Cell Freezing Media
- Microbial Cell Freezing Media
- Cryoprotectant Type Insights (Revenue, USD Bn, 2020 - 2032)
- DMSO-containing Media
- DMSO-free Media
- Glycerol-based Media
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Stem Cell Preservation
- Tissue Preservation
- Sperm Freezing
- Oocyte and Embryo Freezing
- Regenerative Medicine
- Formulation Insights (Revenue, USD Bn, 2020 - 2032)
- Ready-to-use Formulations
- Custom/Research-grade Formulations
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- Cell Banks and Biorepositories
- Contract Research Organizations (CROs)
- Others (Academic and Research Institutes, etc.)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific Inc.
- Cytiva (Danaher Corporation)
- Merck KGaA (Sigma-Aldrich)
- Lonza Group AG
- STEMCELL Technologies Inc.
- BioLife Solutions Inc.
- Corning Incorporated
- HiMedia Laboratories Pvt. Ltd.
- FUJIFILM Irvine Scientific Inc.
- MP Biomedicals LLC
- AMSBIO (AMS Biotechnology)
- Nacalai Tesque Inc.
- Cell Applications Inc.
- Miltenyi Biotec B.V. and Co. KG
- Sartorius AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Cell Freezing Media Market, By Product Type
- Global Cell Freezing Media Market, By Cell Type
- Global Cell Freezing Media Market, By Cryoprotectant Type
- Global Cell Freezing Media Market, By Application
- Global Cell Freezing Media Market, By Formulation
- Global Cell Freezing Media Market, By End User
- Global Cell Freezing Media Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Cell Freezing Media Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Serum-containing Freezing Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Serum-free Freezing Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Protein-free Freezing Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chemically-defined Freezing Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Cell Freezing Media Market, By Cell Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Mammalian Cell Freezing Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Stem Cell Freezing Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Primary Cell Freezing Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Insect Cell Freezing Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Microbial Cell Freezing Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Cell Freezing Media Market, By Cryoprotectant Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- DMSO-containing Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- DMSO-free Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Glycerol-based Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Cell Freezing Media Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Stem Cell Preservation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Tissue Preservation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sperm Freezing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oocyte and Embryo Freezing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Cell Freezing Media Market, By Formulation, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Ready-to-use Formulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Custom/Research-grade Formulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Cell Freezing Media Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hospitals and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cell Banks and Biorepositories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Academic and Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Cell Freezing Media Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cytiva (Danaher Corporation)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA (Sigma-Aldrich)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- STEMCELL Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioLife Solutions Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Corning Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HiMedia Laboratories Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- FUJIFILM Irvine Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MP Biomedicals LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AMSBIO (AMS Biotechnology)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nacalai Tesque Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cell Applications Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Miltenyi Biotec B.V. and Co. KG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sartorius AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About Us
